category,datetime,headline,id,image,related,source,summary,url
company,1769445300,Eli Lilly or Viking Therapeutics: Which Stock Is More Likely to be a Millionaire-Maker?,138263442,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,Both companies may succeed in this industry.,https://finnhub.io/api/news?id=14795873dba9657a5f97b023a3e810060ebea159d24c5705d16fb8726bd13920
company,1769443108,NVIDIA Just Made a Bigger Push Into AI Drug Discovery,138263349,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,"Shares of GPU titan Nvidia (NASDAQ:NVDA) may have been stuck in a sideways channel for the past six months, but a lot has been going on behind the scenes amid the intense sideways action. Of course, Nvidia isn’t solely to blame for the recent consolidation. In fact, the Magnificent Seven players have really run out ... NVIDIA Just Made a Bigger Push Into AI Drug Discovery",https://finnhub.io/api/news?id=767d11859a0547870807b7e3b5f0a3fc724f4e0410d668f21ad0965d12770302
company,1769437200,Prediction: This Healthcare Stock Could Soar by 40% in 2026,138262041,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,"This pharmaceutical giant has recently caught fire, and the stock's run is likely just beginning.",https://finnhub.io/api/news?id=0e15991612e19e5086ab6c5e4bc9d52bd408022ed15c79a1daaaeb24c0ffb7b5
company,1769436900,How Will Ozempic and Wegovy Sales Aid NVO's Upcoming Q4 Results?,138263444,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,Novo Nordisk's Q4 results hinge on Ozempic and Wegovy sales as demand growth slows amid guidance cuts due to intense rivalry and compounded drug headwinds.,https://finnhub.io/api/news?id=b245a1d37a1061dd735b360959d41dd6fdc0b59f24b202d192a28f26be6cc6db
company,1769430300,My Top AI Healthcare Stock to Buy and Hold for 20 Years,138261228,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,This drugmaker continues to strengthen its investment thesis.,https://finnhub.io/api/news?id=d708dff3988001e204eddf6864435be283a99cda2fe5fceace8eb00b10b57be7
company,1769430120,"Downstream Processing Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) and Competitive Intelligence",138261229,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,"The market is poised for growth (12.88% CAGR), driven by high demand for equipment due to capacity expansions, and the adoption of single-use systems, continuous bioprocessing, and digital twinsDublin, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The ""Downstream Processing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)"" has been added to ResearchAndMarkets.com's offering. The global downstream processing market is poised for significant growth, increasing from USD 40.78",https://finnhub.io/api/news?id=81f2008f8a7e73c961dbcde84f2034e922c63f34d56bfa608f8a9cbfa0a00a59
company,1769426493,Novo Nordisk: The Q4 Setup Favors Another Beat (Earnings Preview),138262477,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1219304819/image_1219304819.jpg?io=getty-c-w1536,LLY,SeekingAlpha,"Novo Nordisk A/S Q3 costs, Q4 savings, and oral Wegovy launch drive EPS upside. Click for this NVO stock update and earnings preview.",https://finnhub.io/api/news?id=1b1f55bb0d13606e0b2bfcdf93e8a0c078a23f697bb7df9bc152d5907481beb4
company,1769425485,"Drugmakers turn to AI to speed trials, regulatory submissions",138260333,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,"By Maggie Fick and Michael Erman SAN FRANCISCO, Jan 26 (Reuters) - Artificial intelligence has yet to deliver on the most challenging aspect of drug development -- finding new molecules that lead to",https://finnhub.io/api/news?id=5c70f399df4243bfaeee2c033315dce74ad35b423c041c04b5b4240727ca7180
company,1769423631,"NVIDIA (NVDA)’s Stock “Can’t Get Out of its Way,” Says Jim Cramer",138260335,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,LLY,Yahoo,"We recently published 14 Stocks Jim Cramer Talked About. NVIDIA Corporation (NASDAQ:NVDA) is one of the stocks Jim Cramer talked about. NVIDIA Corporation (NASDAQ:NVDA) continues to be on Jim Cramer’s radar. The CNBC TV host has continued to defend the stock even though gains have stalled lately. Since early November, the shares are down by […]",https://finnhub.io/api/news?id=3881b9796cff9f36232a3c3dbd37876389994bd9c8af251f48c2b6b5edee719d
